Press releases
- FDA approves Trelegy Ellipta as the first once-daily single inhaler triple therapy for the treatment of both asthma and COPD in the US
- Sanofi and GSK initiate Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate
- Vir Biotechnology and GSK start phase 2/3 study of COVID-19 antibody treatment
Tweets from GSK US
-
GSKUS @GSKUS
Missed our announcement yesterday about our $10M commitment over 10 yrs. to help increase the number of diverse students in #Philly who become #STEM professionals? Hear more from Maya, our President, US Pharma on how we’re confronting inequity in STEM 👉gsk.to/2DT352x8
about 37 days ago
o
-
GSKUS @GSKUS
#MultipleMyeloma is the second most common form of blood #cancer, with an estimated 32,000 new cases of the disease to be diagnosed in the U.S. in 2020.
about 38 days ago -
GSKUS @GSKUS
We know that together unique perspectives enhance our ability to innovate & respond to diverse needs of communities we serve, which is how we were able to develop the #PhillySTEMEquity Collective; to increase the number of diverse #Philly students who become STEM professionals.👇
about 38 days ago
